K.V. YANAKOVA¹, L.E. TEREGULOVA^2,3, Z.I. VAFINA², M.G. TUKHBATULLIN³

¹Municipal Clinical Hospital № 7, 54 Marshala Chuykova St., Kazan, Russian Federation 420136

²Republican Clinical Hospital of Ministry of Health of the Republic of Tatarstan, 138 Orenburgskiy Trakt St., Kazan, Russian Federation 420064

³Kazan State Medical Academy, 36 Butlerova St., Kazan, Russian Federation 420012

Yanakova K.V. — postgraduate student of the department of ultrasound diagnosis,tel. +7-905-377-11-69, e-mail: xristinaki_80@hotmail.com¹

Teregulova L.E. —Candidate of Medical Science,Head of the division of ultrasound investigation, assistant professor of the department of ultrasound diagnosis, tel. (843) 264-54-14, e-mail: tereg1@mail.ru^2,3

Vafina Z.I. —Head of medicogenetic center, tel. +7-917-265-82-20, e-mail: vzulfia@mail.ru²

Tukhbatullin M.G. —D.Med.Sc., Professor, Head of the department of ultrasound diagnosis, tel. +7-900-326-20-03, e-mail: Munir.Tuhbatullin@tatar.ru³

The article presents the results of ultrasound investigation of the cervix uteri of 100 pregnant women at 11-13,6 weeks of pregnancy. Measurement of the cervix uteri was made by standards recommended by the Fetal Medicine Foundation. In the framework of a combined screening of the first trimester was defined the level of biochemical markers of chromosomal abnormalities: β-hCG (chorionic gonadotropin), PAPP-A (pregnancy-associated plasma protein-A). Were obtained data of direct correlation of length of the cervix and the level of PAPP-A (pregnancy-associated plasma protein-A), as well as of no correlation with the level of β-hCG.

Key words: combined screening of the first trimester, cervix uteri, biochemical markers of chromosomal abnormalities, β-hCG (chorionic gonadotropin), PAPP-A (pregnancy-associated plasma protein-A).

 

REFERENCES

1. Nicolaides K.H. Screening for fetal aneuploidies at 11 to 13 weeks. Prenat. Diagn., 2011, no. 31 (1), pp. 7-15.

2. Kosovtsova N.V. Diagnosticheskie vozmozhnosti ekhografii v vyyavlenii vrozhdennykh porokov razvitiya v rannie sroki beremennosti: avtoref. dis. … dok. med. nauk [Diagnostic capabilities of ultrasound in the detection of congenital malformations in early pregnancy. Synopsis of the dissertation of Doctor Med. sci.]. Moscow, 2007. 32 p.

3. Tamazyan G.V., Zhuchenko L.A. Organisation of events prenatal screening of congenital malformations in the Moscow Region. Zhurnal akusherstva i zhenskikh bolezney, 2009, vol. LVIII, iss. 6, pp. 76-80 (in Russ.).

4. Zhuchenko L.A., Andreeva E.N., Voskoboeva E.Yu. Implementation of activities of the National Project «Prenatal (prenatal) diagnosis of the child’s development» in the Moscow Region. Rossiyskiy vestnik akushera-ginekologa, 2013, no. 4, pp. 6-12 (in Russ.).

5. Nikiforovskiy N.K., Stepan’kova E.A., Lukina N.V. The role of modern methods of prenatal diagnosis to identify chromosomal abnormalities in the fetus. Okhrana materinstva i detstva, 2009, no. 1 (13), pp. 54-56 (in Russ.).

6. Teregulova L.E., Vafina Z.I., Abuseva A.V. et al. Analysis of the results of mass centralized prenatal screening I trimester of pregnancy in the Republic of Tatarstan for 2012. Prakticheskaya meditsina, 2013, vol. 2, no. 1, 2, pp. 150-155 (in Russ.).

7. Shiefa S., Amargandh M. First Trimester Maternal Serum Screening Using Biochemical Markers PAPP-A and Free β-hCG for Down Syndrome, Patau Syndrome and Edward Syndrome. Indian J. Clin. Biochem., 2013, no. 28(1), pp. 3-12.

8. Brügger-Andersen T., Bostad L. The activity of pregnancy-associated plasma protein A (PAPP-A) as expressed by immunohistochemistry in atherothrombotic plaques obtained by aspiration thrombectomy in patients presenting with a ST-elevation myocardial infarction: a brief communication. Thromb J., 2010, no. 8 (1), p. 1.

9. Body R., Ferguson C. Pregnancy associated plasma protein A: a novel cardiac marker with promise. Emerg. Med. J., 2006, November, no. 23 (11), pp. 875-877.

10. Joyce LeFever Kee. Laboratory and Diagnostic. Prentice Hall, 8-e ed., 2010. 876 r.

11. Wendy L. Arneson, Jean M. Brickell. Clinical Chemistry. A Laboratory Perspective. F.A. Davis Company, 2007.

12. Celik E., To A.M., Gajewska K. et al.Fetal Medicine Foundation Second Trimester Screening Group. Cervical length and obstetric history predict spontaneous preterm birth: development and validation of a model to provide individualized risk assessment. Ultrasound Obstet. Gynecol., 2008, vol. 31, pp. 549-54.

13. Souka A.P., Papastefanou I., Michalitsi V.et al.A predictive model of short cervix at 20-24 weeks using first-trimester cervical length measurement and maternal history. Prenat. Diagn., 2011, vol. 31, pp. 202-206.

14. Greco E., Gupta R., Syngelaki A. et al. First trimester screening for spontaneous preterm delivery with maternal characteristics and cervical length. Fetal Diagn. Ther., 2012, vol. 31, pp. 154-161.